• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MEM
Click for more information
12.5% 0.9¢

MEMPHASYS LIMITED. - News & Media

Market Cap $12.31M  ! watchlist Created with Sketch. Add to my watchlist
Technology Scientific & Technical Instruments

Memphasys Limited is an Australia-based reproductive biotechnology company. The Company... Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing novel medical devices, diagnostics, and media with applications to assisted reproduction technology (ART) in humans and animals. Its reproductive biotechnology products in development include medical devices, in vitro diagnostics, and new proprietary media. The Company's product pipeline includes Felix, ROSA, and AI-Port. The Felix is a patented, automated device for quickly separating high quality sperm from semen for use in human in vitro fertilization (IVF) procedures without causing damage to DNA. Felix has a sizable target market worldwide. The Company’s ROSA is an in vitro diagnostic that assesses semen and blood samples for the presence of oxidative stress. The AI-Port stores and transports animal semen for artificial insemination (AI) for up to four days without the harmful effects of freezing sperm used in standard AI procedures in livestock.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Memphasys' (ASX:MEM) FELIX system records 10 new healthy births in India

Memphasys (ASX:MEM) has announced that its patented sperm isolation technology has resulted in 10 new births in India for couples experiencing difficulties conceiving a child.

15 Sep 2023 14:50 (AEST)

Memphasys (ASX:MEM) welcomes first baby born in India using Felix system

Reproductive biotechnology company Memphasys (ASX:MEM) has completed the first commercial sale of its Felix system to a clinic in Japan.

03 Apr 2023 09:56 (AEST)



(20min delay)
Last
0.9¢ 		Change
0.001(12.5%) 		Mkt cap ! $12.31M
Open High Low Value Volume
0.8¢ 0.9¢ 0.8¢ $3.348K 404.6K

Buyers (Bids)

No. Vol. Price($)
1 125000 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1285222 5
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
0.9¢ 		  Change
0.001 ( 28.6 %)
Open High Low Volume
0.8¢ 0.9¢ 0.8¢ 802611
Last updated 12.24pm 03/05/2024 ?
MEM (ASX) Chart

Top Stories

Lithium Universe ends the quarter charged up for Quebec Refinery roll-out

Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
Infini Resources gearing up for UAV geophys survey over Portland Creek Infini Resources has announced its execution of an application for UAV-based geophysical surveys over its Portland Creek Uranium Project.
BPH Energy renews NT Bonaparte Basin permit BPH Energy (ASX:BPH) announced on Friday that it has renewed a key licence in the Northern Territory (NT) overlying the Bonaparte Basin.
Provident Aurum's off-market bid sends Sihayo shares soaring Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.
Sold out signs go up for RIU Resources Roundup in Sydney More than 115 companies will be participating in this year's RIU Resources Roundup in Sydney.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.